블로그

C형 간염

하보니: 만성 C형 간염을 치료하는 항바이러스제

Harvoni patient's highlighted liver

Harvoni is a prescription-only medication used to treat chronic hepatitis C in adults and children aged 3 and above. Harvoni is an antiviral drug that is taken once a day orally. 

Harvoni Treatment Info

사전 승인을 받으세요
(877) 778-0318

Sofosbuvir and ledipasvir are the two active components. Ledipasvir blocks a protein called HCV NS5A necessary for the multiplication of the hepatitis C virus. Sofosbuvir interferes with the reproduction of the genetic material required for the replication of the virus.

What Is Harvoni?

Harvoni is an FDA-approved direct-acting antiviral medication used to treat various forms of hepatitis C.

Before taking this medication, it is crucial to tell your doctor and pharmacist:

  • If you are allergic to any drug, especially sofosbuvir or ledipasvir.
  • If you have any disorders such as liver issues, hepatitis B, or diabetes.
  • If you take any prescription, over-the-counter, or herbal drugs.
  • If you are breastfeeding, pregnant, or planning to become pregnant. Harvoni’s safety during pregnancy and breastfeeding is unknown. Contact your doctor and pharmacist about the risk-benefit ratio of taking Harvoni.

What Is Harvoni Used To Treat?

Harvoni is used to treat hepatitis C, a chronic viral infection that causes inflammation in the liver. It is suggested for adults and children over the age of three who have chronic hepatitis C with or without 경화증.

Hepatitis C genotypes are six distinct species or strains of the virus. Harvoni is used to treat a variety of hepatitis C virus genotypes, including genotypes 1, 4, 5, and 6.

How Does Harvoni Work?

Harvoni works by inhibiting the proteins required for hepatitis C virus growth and replication. It also prevents the hepatitis C virus from reproducing its genetic material, stopping the infection from growing.

Both of the active components of Harvoni, sofosbuvir and ledipasvir, have a role in the treatment of hepatitis C.

Ledipasvir works by interfering with a protein called HCV NS5A, which is involved in viral replication. Sofosbuvir prevents the replication of genetic material by inhibiting an RNA-dependent polymerase known as HCV NS5B, which is required for the virus’s proliferation and replication.

How Is Harvoni Administered?

  • Harvoni should be taken exactly as prescribed and recommended by your doctor or pharmacist.
  • Harvoni can be taken with or without food.
  • Harvoni is often taken orally once daily as tablets or pellets for 8 to 12 weeks, depending on your prescription.
  • Harvoni should be taken at the same time every day.
  • Harvoni tablets should be swallowed as a whole with one glass of water. Do not break, split, crush, or chew the tablets.
  • Harvoni oral pellets can be administered by sprinkling and mixing it with non-acidic soft food or swallowing it without food. Examples of non-acidic soft foods include mashed potatoes, ice cream, chocolate syrup, or puddings.
  • Any leftover mixtures of Harvoni pellets should be discarded and not stored for later use.
  • If you forget to take a dose, take it as soon as you remember. Two dosages should never be taken on the same day.

전문가와 상담하세요

공제금 지원에 관하여
상담 일정을 잡으세요

Drug Interactions

The following drugs should not be taken with Harvoni because they may interfere with the drug’s reaction or slow its removal from your body.

  • Amiodarone
  • Flibanserin
  • Rosuvastatin
  • Rifampin
  • 페니토인
  • Phenobarbital
  • Carbamazepine
  • Primidone

Harvoni Side Effects

Harvoni patient suffering from cough as a side effect

Most of Harvoni’s side effects are minor and disappear as your body adjusts to the medication. But if the side effects become severe or persistent, consult your doctor immediately.

Common side effects include: 

  • 메스꺼움
  • 설사 
  • 두통
  • 기침
  • Sleep disturbances
  • 호흡 곤란
  • 근육통
  • 피로

Severe side effects include: 

  • Swelling of the face, throat, or tongue
  • 발진
  • 심한 현기증
  • 알레르기 반응
  • 호흡곤란

Alcohol use while taking Harvoni may increase the chance of side effects and exacerbate liver inflammation and scarring.

Harvoni comes in two oral dosage forms: pellets and tablets.

Tablets come in the following strengths:

  • 90 mg/400 mg (This strength contains 90 mg of ledipasvir and 400 mg sofosbuvir.)
  • 45 mg/200 mg (This strength contains 45 mg ledipasvir and 200 mg sofosbuvir.)

Pellets come in the following strengths:

  • 45 mg/200 mg (This strength contains 45 mg ledipasvir and 200 mg sofosbuvir.)
  • 33.75 mg/150 mg (This strength contains 33.75 mg ledipasvir and 150 mg sofosbuvir.)

Dosage Information

The recommended dose for adults is one 90 mg ledipasvir/400 mg sofosbuvir given once daily.

The dose for children is based on body weight: 

  • Children with a body weight of less than 35 kg with hepatitis C virus are given 45 mg/200 mg once daily.
  • Children weighing 35 kg or more are given a 90 mg/400 mg dose of Harvoni once daily.

공제금 지원 받기

재정 지원
(877) 778-0318

How Much Does Harvoni Cost?

The cost of Harvoni depends on several factors, including:

  • The type of pharmacy and its location.
  • The duration of your treatment.
  • The dose and dosage form of Harvoni prescribed by your doctor.
  • Whether the price of the Harvoni drug is covered by your health insurance.

On average, the cost of Harvoni is approximately $65,000 for an 8-week treatment, $98,500 for a 12-week treatment, and $197,000 for a 24-week treatment without insurance. Financial assistance is available for those who cannot afford the medication. 

자주 묻는 질문

Does Harvoni completely cure hepatitis C?

Yes. The cure rate of Harvoni drug is around 94% to 99% when you don’t have any other severe disease or complications. After 12 weeks of treatment, in most cases, there is no virus seen in the patient’s bloodstream.

How long is the treatment?

The duration of Harvoni treatment depends on the severity of the patient’s condition, the amount of hepatitis C virus present in the bloodstream of the patient, and whether or not the patient has cirrhosis with hepatitis C. Harvoni medication is prescribed once daily for approximately 8 to 24 weeks of treatment.

이 정보는 의학적 조언이나 치료를 대체할 수 없습니다. 새로운 치료를 시작하기 전에 담당 의사 또는 의료 서비스 제공자와 건강 상태에 대해 상담하십시오. AmeriPharma® Specialty Care는 제공된 정보 또는 그 결과로 내려진 진단이나 치료에 대해 어떠한 책임도 지지 않으며, 콘텐츠의 신뢰성에 대해서도 책임을 지지 않습니다. AmeriPharma® Specialty Care는 여기에 나열된 모든 웹사이트/기관을 운영하는 것은 아니며, 해당 콘텐츠의 가용성이나 신뢰성에 대해서도 책임을 지지 않습니다. 이러한 목록은 AmeriPharma® Specialty Care의 보증, 후원 또는 추천을 암시하거나 구성하지 않습니다. 이 웹페이지에는 AmeriPharma® Specialty Care와 제휴하지 않은 제약 회사의 상표 또는 등록 상표인 브랜드 처방약에 대한 참조가 포함될 수 있습니다.
의학적으로 검토됨 Martina Mikail 박사, PharmD

마르티나 미카일 약학박사는 이집트에서 태어나 펜실베이니아와 캘리포니아에서 자랐습니다. 2022년 5월 마셜 B. 케첨 대학교를 졸업했습니다. 미카일 박사는 USPS 리더십 어워드와 CSHP 리더십 어워드를 수상했으며, CSHP, ASHP, 그리고 APhA의 정회원으로 활동하고 있습니다. 그녀의 업무에서 가장 보람 있는 부분은 환자 교육 및 약물 상담입니다. 여가 시간에는 요리, 가족과의 시간 보내기, 그리고 독서를 즐깁니다.

문의하기

아래 HIPAA 규격 양식을 사용하여 처방전 재조제를 요청하세요. 복용 중인 약이나 복용 방법에 대한 문의 사항이 있으시면 문의하기 페이지를 방문하시거나 다음 번호로 전화해 주세요. (877) 778-0318.

HIPAA Compliant

제출하면 AmeriPharma에 동의하는 것입니다. 이용 약관, 개인정보 보호정책, 그리고 개인정보 보호 관행 고지

ko_KRKorean